fibrinogen has been researched along with Atypical Endometrial Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|
1 trial(s) available for fibrinogen and Atypical Endometrial Hyperplasia
Article | Year |
---|---|
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
Topics: Aged; Cholesterol, HDL; Double-Blind Method; Drug Administration Schedule; Endometrial Hyperplasia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Glucose; Heart Diseases; Humans; Insulin; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Risk Factors; Systole; Weight Gain | 1995 |